Press Release: Availability of Transgene's 2024 Universal Registration Document (URD)

Dow Jones

Apr 11, 2025

Availability of Transgene's 2024 Universal Registration Document (URD)

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that the French version of its 2024 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers -- AMF) on April 10, 2025, under number D.25-0243.

This document, available on the AMF's website (www.amf-france.org), can be viewed and downloaded (in PDF format in French and English, and in ESEF format in French only) on Transgene's website (www.transgene.fr)

It includes the following documents:

   -- the Annual Financial Report; 
 
   -- the Board of Directors' Corporate Governance Report; 
 
   -- the Statutory Auditors' Reports; 
 
   -- information on the Company's share capital, including the share buyback 
      program; 
 
   -- information on the Statutory Auditors' fees.

The Universal Registration Document also includes information on the Company's Environmental, Social and Governance $(ESG)$ factors.

Attachment

   -- 20250410_Transgene_publication_URD_2024_EN

(END) Dow Jones Newswires

April 10, 2025 14:15 ET (18:15 GMT)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2526517781"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2526517781\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2526517781?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-11 02:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2526517781","market":"nz","top_or_hot":-1,"title":"Press Release: Availability of Transgene's 2024 Universal Registration Document (URD)","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     Availability of Transgene's 2024 Universal Registration Document (URD) \n</p>\n<p>\n     Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that the French version of its 2024 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers -- AMF) on April 10, 2025, under number D.25-0243. \n</p>\n<p>\n     This document, available on the AMF's website (www.amf-france.org), can be viewed and downloaded (in PDF format in French and English, and in ESEF format in French only) on Transgene's website (www.transgene.fr) \n</p>\n<p>\n     It includes the following documents: \n</p>\n<pre>\n   -- the Annual Financial Report; \n \n   -- the Board of Directors' Corporate Governance Report; \n \n   -- the Statutory Auditors' Reports; \n \n   -- information on the Company's share capital, including the share buyback \n      program; \n \n   -- information on the Statutory Auditors' fees. \n</pre>\n<p>\n     The Universal Registration Document also includes information on the Company's Environmental, Social and Governance <a href=\"https://laohu8.com/S/ESG\">$(ESG)$</a> factors. \n</p>\n<p>\n     Attachment \n</p>\n<pre>\n   -- 20250410_Transgene_publication_URD_2024_EN \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 10, 2025 14:15 ET (18:15 GMT)\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Press Release: Availability of Transgene's 2024 Universal Registration Document (URD)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPress Release: Availability of Transgene's 2024 Universal Registration Document (URD)\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-11 02:15</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     Availability of Transgene's 2024 Universal Registration Document (URD) \n</p>\n<p>\n     Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that the French version of its 2024 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers -- AMF) on April 10, 2025, under number D.25-0243. \n</p>\n<p>\n     This document, available on the AMF's website (www.amf-france.org), can be viewed and downloaded (in PDF format in French and English, and in ESEF format in French only) on Transgene's website (www.transgene.fr) \n</p>\n<p>\n     It includes the following documents: \n</p>\n<pre>\n   -- the Annual Financial Report; \n \n   -- the Board of Directors' Corporate Governance Report; \n \n   -- the Statutory Auditors' Reports; \n \n   -- information on the Company's share capital, including the share buyback \n      program; \n \n   -- information on the Statutory Auditors' fees. \n</pre>\n<p>\n     The Universal Registration Document also includes information on the Company's Environmental, Social and Governance <a href=\"https://laohu8.com/S/ESG\">$(ESG)$</a> factors. \n</p>\n<p>\n     Attachment \n</p>\n<pre>\n   -- 20250410_Transgene_publication_URD_2024_EN \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 10, 2025 14:15 ET (18:15 GMT)\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"UVV","symbol_name":"环球烟草","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2526517781","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2526517781","pubTimestamp":1744308900,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Transgene , a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that the French version of its 2024 Universal Registration Document was filed with the French Financial Markets Authority  on April 10, 2025, under number D.25-0243.This document, available on the AMF's website , can be viewed and downloaded  on Transgene's website . -- the Board of Directors' Corporate Governance Report;-- information on the Company's share capital, including the share buyback. The Universal Registration Document also includes information on the Company's Environmental, Social and Governance  factors.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"UVV":"环球烟草","BK4075":"烟草","ESG":"FlexShares STOXX US ESG Select Index Fund"},"translate_title":"新闻稿：Transgene 2024年通用注册文件(URD)的可用性","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"UVV":1,"ESG":1},"content_text":"Availability of Transgene's 2024 Universal Registration Document (URD) \n\n\n     Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that the French version of its 2024 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers -- AMF) on April 10, 2025, under number D.25-0243. \n\n\n     This document, available on the AMF's website (www.amf-france.org), can be viewed and downloaded (in PDF format in French and English, and in ESEF format in French only) on Transgene's website (www.transgene.fr) \n\n\n     It includes the following documents: \n\n\n   -- the Annual Financial Report; \n \n   -- the Board of Directors' Corporate Governance Report; \n \n   -- the Statutory Auditors' Reports; \n \n   -- information on the Company's share capital, including the share buyback \n      program; \n \n   -- information on the Statutory Auditors' fees. \n\n\n     The Universal Registration Document also includes information on the Company's Environmental, Social and Governance $(ESG)$ factors. \n\n\n     Attachment \n\n\n   -- 20250410_Transgene_publication_URD_2024_EN \n\n\n  (END) Dow Jones Newswires\n\n\n  April 10, 2025 14:15 ET (18:15 GMT)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}